NDC 83854-002-01 - LACOSAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83854-002
- Requested NDC
- 83854-002-01
- Package NDCs from labels
- 83854-002-01, 83854-002-10
- Manufacturer
- Anthea Pharma Private Limited
- Effective date
- 2026-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACOSAMIDE - Anthea Pharma Private Limited | Anthea Pharma Private Limited | 2026-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83854-002-01 | LACOSAMIDE | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 5 | |
| 83854-002-10 | LACOSAMIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lacosamide Oral Solution | LACOSAMIDE | Chartwell Governmental & Specialty RX, LLC. | e265fd09-8149-4423-a317-5760d34b8e9b | 2026-02-25 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide Oral Solution | LACOSAMIDE ORAL | Florida Pharmaceutical Products, LLC | ba4e2e28-7dc3-47b3-9c2c-34e0b1f39fb8 | 2026-02-12 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Kanchan Healthcare Inc | 41f02424-231d-4039-a122-df4b49dc9998 | 2026-01-29 | Warnings, Adverse reactions | 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Anthea Pharma Private Limited | b4f2620a-2047-4b33-bb75-18702f6c55e6 | 2026-01-24 | Warnings, Adverse reactions | ANDA220268 83854-002-01 83854-002-10 83854-002 83854000201 809974 491d8945-109a-8c82-e063-6394a90a7a04 b4f2620a-2047-4b33-bb75-18702f6c55e6 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | GLENMARK PHARMACEUTICALS INC., USA | bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc | 2026-01-24 | Warnings, Adverse reactions | ANDA220268 809974 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Virtus Pharmaceuticals, LLC | 01162e2f-967b-4596-8188-c0d9889c3814 | 2026-01-23 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Sintetica US LLC | 08ac486a-4f61-4e9e-9683-d1a66a6c2a4d | 2026-01-04 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| Lacosamide Oral Solution | LACOSAMIDE | Ajenat Pharmaceuticals LLC | cb29da34-89aa-405a-8fbc-2308bda37187 | 2025-12-29 | Warnings, Adverse reactions | 563KS2PQY5 |
| lacosamide | LACOSAMIDE | Glenmark Pharmaceuticals Inc. USA | df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c | 2025-12-17 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide Oral Solution | LACOSAMIDE | Kesin Pharma Corporation | 446f14be-5d79-26b9-e063-6294a90ae0b5 | 2025-11-25 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Kanchan Healthcare Inc | 5c03b90e-6985-4005-b6c5-44626d0600d7 | 2025-10-19 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide Oral Solution | LACOSAMIDE ORAL SOLUTION | Ascend Laboratories, LLC | 4ae87834-05d8-43c8-aaa3-78047d4a573c | 2025-10-09 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | NorthStar RxLLC | 9dffda6c-9e44-478f-9e02-9da3ab4c50e1 | 2025-10-05 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Camber Pharmaceuticals, Inc. | bbd80370-3d23-41f8-8914-c6ea897c0154 | 2025-09-29 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Ascend Laboratories, LLC | 9d7fde23-dc3f-41e9-89cf-6a1a9eeaa7de | 2025-08-11 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide Oral Solution | LACOSAMIDE | Kesin Pharmaceutical Corporation | 3ba29442-4e8a-c2b2-e063-6294a90a1bbf | 2025-08-05 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Westminster Pharmaceuticals, LLC | 61e3747a-3957-4840-81f0-313aefbd5d2b | 2025-07-29 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| MOTPOLY XR | LACOSAMIDE | Aucta Pharmaceuticals, Inc. | fb8235b4-4cd3-6f22-e053-6294a90a545c | 2025-07-16 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | ANI Pharmaceuticals, Inc. | 68033c90-d9cc-4d5f-896c-9a61a0c3b529 | 2025-06-25 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Advanced Rx of Tennessee, LLC | 325df1b7-4908-0c03-e063-6294a90ad844 | 2025-04-09 | Warnings, Adverse reactions | 563KS2PQY5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.